FineMark National Bank & Trust’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-20
Closed -$1K 1060
2016
Q4
$1K Hold
20
﹤0.01% 1258
2016
Q3
$1K Buy
+20
New +$867 ﹤0.01% 1279

Other funds holding SYNH

FineMark National Bank & Trust's SYNH Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2017, closing a stake of 20 shares — an estimated $1K sold.

FineMark National Bank & Trust first reported a position in SYNH in Q3 2016 and held it in 2 quarters. The position peaked at $1K in Q4 2016. 232 funds tracked by Wall St. Rank hold SYNH as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 20 Syneos Health, Inc. Class A Common Stock shares in Q1 2017, an estimated $1K.
  • FineMark National Bank & Trust first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 2 quarters.
  • FineMark National Bank & Trust's Syneos Health, Inc. Class A Common Stock position peaked at $1K in Q4 2016.
  • 232 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.